Ranesp - Risk Of Severe Skin Reactions: Stevens-johnson Syndrome And Toxic Epidermal Necrolysis

Aranesp Recall Summary Aranesp, a medication distributed across Canada, is being recalled due to reports of severe skin reactions including Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. These conditions cause serious blistering and peeling of the skin and mucous membranes. The recall affects all patients who have been prescribed this drug in Canada.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2017-05-05

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/f773e71f-31a6-414c-86d4-484c1238e0bf